These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2760199)

  • 61. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
    Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
    J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
    Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
    Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epinephrine induces Ca2+ uptake in human blood platelets.
    Owen NE; Feinberg H; Le Breton GC
    Am J Physiol; 1980 Oct; 239(4):H483-H488. PubMed ID: 7425140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.
    Lewy RI; Wiener L; Walinsky P; Lefer AM; Silver MJ; Smith JB
    Circulation; 1980 Jun; 61(6):1165-71. PubMed ID: 7371128
    [No Abstract]   [Full Text] [Related]  

  • 65. Platelet activation during exercise-induced myocardial ischemia.
    Green LH; Seroppian E; Handin RI
    N Engl J Med; 1980 Jan; 302(4):193-7. PubMed ID: 7350460
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?
    Folts JD; Gallagher K; Rowe GG
    Circulation; 1982 Feb; 65(2):248-55. PubMed ID: 7053882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease.
    Hirsh PD; Hillis LD; Campbell WB; Firth BG; Willerson JT
    N Engl J Med; 1981 Mar; 304(12):685-91. PubMed ID: 6894016
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
    Meuleman TR; Hill DC; Port JD; Stanley TH; Pace NL; Mohammad SF
    Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potentiation of coronary vascular platelet adhesion by atrial pacing in the presence of arterial stenosis in dogs.
    Walinsky P; Lefer AM; Frasca P; Santamore W
    J Am Coll Cardiol; 1984 May; 3(5):1252-5. PubMed ID: 6707376
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
    Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Platelet activation by circulating levels of hormones: a possible link in coronary heart disease.
    Ardlie NG; Cameron HA; Garrett J
    Thromb Res; 1984 Nov; 36(4):315-22. PubMed ID: 6523443
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
    Willerson JT; Campbell WB; Winniford MD; Schmitz J; Apprill P; Firth BG; Ashton J; Smitherman T; Bush L; Buja LM
    Am J Cardiol; 1984 Dec; 54(10):1349-54. PubMed ID: 6391133
    [No Abstract]   [Full Text] [Related]  

  • 74. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
    Plow EF; Marguerie GA
    J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
    Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
    J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor.
    Goldberg MR; Robertson D
    Pharmacol Rev; 1983 Sep; 35(3):143-80. PubMed ID: 6140686
    [No Abstract]   [Full Text] [Related]  

  • 77. Effects of adrenaline on human blood platelets.
    Mills DC; Roberts GC
    J Physiol; 1967 Nov; 193(2):443-53. PubMed ID: 6065889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion.
    Steen VM; Holmsen H
    Thromb Haemost; 1985 Oct; 54(3):680-3. PubMed ID: 4089798
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.
    Ogletree ML; Harris DN; Greenberg R; Haslanger MF; Nakane M
    J Pharmacol Exp Ther; 1985 Aug; 234(2):435-41. PubMed ID: 3926986
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
    Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
    Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.